| P-001 | Fast sodium channel inhibition | Sodium channels | Tetrodotoxin | Action Potential genesis and propagation |  |
| P-002 | AMPA-mediated synaptic transmission | AMPA/Kainate receptors | NBQX | Glutamatergic synaptic transmission | |
| P-003 | NMDA receptors competitive antagonist | NMDA receptors | D-AP5 | Long-Term Potentiation | |
| P-004 | GABA-A receptors - Network Excitability | GABA-A receptors | Bicuculline | Epileptiform activity | |
| P-005 | Neurosteroids / GABA-A receptors | GABA-A receptors | Ganaxolone | Allosteric modulation of GABA-A | |
| P-006 | Inhibition of phasic GABA-A receptors | Phasic GABA-A receptors | Gabazin (SR-95531) | GABA-A receptor-mediated fast synaptic transmission | |
| P-007 | DHPG - induced LTD | mGluR1 & mGluR5 receptors | DHPG | LTD induced by mGluR1/mGluR5 activation | |
| P-008 | AMPA/kainate receptors-mediated excitotoxicity | AMPA/kainate receptors | kainate | Excitotoxicity | |
| P-009 | L-type calcium channels / Synaptic Transmission | L-type VDCC | Nifedipine | Modulation of synaptic transmission by VDCC | |
| P-010 | Cholinergic transmission - Alzheimer's disease | Acetylcholinesterase | Physostigmine (Eserine) | cholinergic modulation of glutamate neurotransmission | |
| P-011 | NMDA & nicotinic receptors / Alzheimer's & Parkinson's diseases | NMDA & nicotinic receptors | Memantine | Long-Term Potentiation / Memory | |
| P-012 | H3 histamine receptor-dependent depression in Dentate Gyrus | H3 histamine receptor | R-alpha-methylhistamine | Pre-synaptic H3 receptor | |
| P-013 | Histamine receptors mediated increase of CA1 pyramidal neurons firing | H1 and H2 histamine receptors | Histamine | CA1 pyramidal neurons spontaneous activity | |
| P-014 | mGluR2-mediated depression of synaptic transmission at MPP synapses | mGluR2 receptors | DCG-IV | pre-synaptic mGluR2 receptors | |
| P-015 | dopamine-induced increase of synaptic transmission and plasticity | D1/D5 dopamine receptors | SCH23390 | dopaminergic modulation of synaptic transmission | |
| P-016 | Model of 4-AP-induced epilepsy | K+ channel | Phenytoin / Carbamazepine | In vitro epilepsy model | |
| P-017 | Model of low-magnesium-induced epilepsy | NMDA receptor | Phenytoin / Carbamazepine | In vitro epilepsy model | |
| P-018 | Model of bicuculline-induced epilepsy | GABA-A receptor | Somatostatin | In vitro model of epilepsy | |
| P-019 | Model of cholinergic-induced epilepsy | GABA-A / M1muscarinic receptors | diazepam | In vitro epilepsy model | |
